Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments
Investors are noticing ripe opportunity in Cytokinetics, a late-stage biopharma company targeting medicines for specialty heart diseases, that has seen ...
Friday, June 26, 2026
Tag: biotech
Insiders Are Scooping Up Shares of a Miner, a Driller, and a Biotech
While insider buying is typically slower when markets are near all-time highs and when earnings-reporting season is in full swing, ...
Dublin biotech Aerska launches with €17.8M Seed round to tackle Alzheimer’s and Parkinson’s
Dublin-based Aerska, a biotechnology company specialising in the treatment of neurological diseases, announced its launch along with $21M (approximately €17.8M) ...
What’s Behind ARK’s $46 Million Bet on Biotech?
Artificial intelligence is already transforming industries from finance to manufacturing. But its biggest impact could come in healthcare, a field ...
Coffee Break: Biotech vs. Science, NIH Under New Management, More on Malaria, Dreams of De-Extinction, and an Aside on the State of America
Part the First: Is This How to Do Science? San Diego, with the University of California-San Diego and the Scripps ...
-1024x683.jpg "Florida Roads Become a Battleground for Illegal Immigration")
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.